MEDICINES Citation, commencement and interpretation 1 1 This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Amendment Order 1993, and shall come into force on 23rd August 1993. 2 In this Order— “the principal Order ” means the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Order 1983 . Amendment of article 3 of the principal Order 2 In article 3(1)(a) of the principal Order (medicinal products on prescription only), for “Article 4(1), (1A), (1B), (1C), (1D) and (1E)”there is substituted “Article 4(1) to (1J)”. Amendment of article 4 of the principal Order 3 In article 4 of the principal Order (medicinal products that are not prescription only), the following paragraphs are inserted after paragraph (1E): 1F Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance acrivastine where— a the medicinal product is sold or supplied in a container or package containing not more than 240 milligrams of acrivastine; b its container or package is labelled to show a maximum daily dose of 24 milligrams of acrivastine. 1G Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance cetirizine where— a the medicinal product is sold or supplied in a container or package containing not more than 100 milligrams of cetirizine; b its container or package is labelled to show a maximum daily dose of 10 milligrams of cetirizine. 1H Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance ketoprofen where— a the maximum strength of the ketoprofen in the medicinal product does not exceed two point five per cent.calculated in terms of weight in weight; b the medicinal product is sold or supplied in a container or package containing not more than 30 grams of the medicinal product; c the medicinal product is indicated only for treatment by external topical application, for rheumatic and muscular pain in adults and in children over the age of 12 years, for a maximum period of 7 days. 1I Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance loratadine where— a the medicinal product is sold or supplied in a container or package containing not more than 100 milligrams of loratadine; b its container or package is labelled to show a maximum daily dose of 10 milligrams of loratadine. 1J Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance terfenadine where— a the medicinal product is sold or supplied in a container or package containing not more than 1200 milligrams of terfenadine; b its container or package is labelled to show a maximum daily dose of 120 milligrams of terfenadine. . Amendment of Part I of Schedule 1 to the principal Order 4 In Part I of Schedule 1 to the principal Order (which lists substances which render a medicinal product a prescription only medicine except in circumstances also listed) the following substances are inserted at the appropriate points in the alphabetical order of the substances listed in column 1: Acemetacin Acitretin Aclarubicin Hydrochloride Acrivastine Adenosine Albendazole Aldesleukin Alfuzosin Hydrochloride Azithromycin Bambuterol Hydrochloride Cefixime Cefodizime Sodium Cefpodoxime Proxetil Celiprolol Hydrochloride Cetirizine Cilastatin Sodium Cilazapril Ciprofibrate Clarithromycin Colfosceril Palmitate Dalteparin Sodium Dexfenfluramine Hydrochloride Diclofenac Potassium Eflornithine Hydrochloride Enoxaparin Sodium Epirubicin Hydrochloride Epoetin Alfa Epoetin Beta Filgrastim Finasteride Flosequinan Fluticasone Propionate Formestane Fosfomycin Trometamol Fosinopril Sodium Gadoteridol Gestrinone Granisetron Hydrochloride Guanfacine Hydrochloride Halofantrine Hydrochloride Imipenem Hydrochloride Iomeprol Iopentol Iothalamic Acid Ioversol Ioxaglic Acid Ketorolac Trometamol Lacidipine Lamotrigine Lomefloxacin Hydrochloride Loratadine Mifepristone Mivacurium Chloride Moclobemide Molgramostim Mometasone Furoate Moracizine Hydrochloride Nafarelin Acetate Nitrendipine Norfloxacin Norgestimate Ofloxacin Ondansetron Hydrochloride Oxaprozin Oxitropium Bromide Oxybutynin Hydrochloride Paroxetine Hydrochloride Perfluamine Pergolide Mesylate Pravastatin Sodium Remoxipride Hydrochloride Risperidone Salmeterol Hydroxynaphthoate Sermorelin Sertraline Hydrochloride Sodium Clodronate Somatorelin Acetate Sultamicillin Sumatriptan Succinate Tazobactam Sodium Terfenadine Tibolone Tinzaparin Tolfenamic Acid Tropisetron Hydrochloride Tulobuterol Tulobuterol Hydrochloride Zuclopenthixol Acetate Amendment of Table A of Part IV of Schedule 1 to the principal Order 5 In Table A of Part IV of Schedule 1 to the principal Order (medicinal products specified by name and product licence number that are not prescription only medicines), immediately after the entry Zenoxone Ointment 0181/0032 there is inserted the following entry: Zovirax Cold Sore Cream 0003/0304 . Signed by authority of the Secretary of State for Health Tom Sackville Parliamentary Under Secretary of State, Department of Health 19th July 1993 John Redwood Secretary of State for Wales 21st July 1993 Fraser of Carmyllie Minister of State Scottish Office 20th July 1993 In witness whereof the Official Seal of the Minister of Agriculture, Fisheries and Food is hereto affixed on the Gillian Shephard Minister of Agriculture, Fisheries and Food 23rd July 1993. Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland this J. Harbison Under Secretary 19th day of July 1993. Sealed with the Official Seal of the Department of Agriculture for Northern Ireland this W. J. Hodges Permanent Secretary 19th day of July 1993.